Vancomycin Market
Vancomycin Market Analysis by Type (Daptomycin, Linezolid, Quinupristin, Ampicillin), by Application (Sepsis, Lung Infection, Skin Soft Tissue Infection, Colitis & Intestinal Inflammation), by Region 0- Global Forecast 2021-2027
Analysis of Vancomycin market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vancomycin Market Outlook (2021-2027)
The global vancomycin market is projected to increase from a valuation of US$ 313.7 Mn in 2020 to US$ 465.1 Mn by the end of 2027. Demand for vancomycin to expand at a CAGR of 5.8% during the forecast period.
|
Report Attributes |
Details |
|
Vancomycin Market Size (2020) |
US$ 313.7 Mn |
|
Projected Year Value (2027) |
US$ 465.1 Mn |
|
Global Market Growth Rate (2021-2027) |
5.8% CAGR |
|
China Market Growth Rate (2021-2027) |
9.4% |
|
Key Companies Profiled |
|
Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Vancomycin from 2017-2020 Vs Market Outlook for 2021-2027
“Rising Prevalence of Infectious Diseases to Stimulate Industry Growth”
The global market for vancomycin was valued at US$ 313.7 Mn in 2020.
Vancomycin is a glycopeptide antibiotic that is used to treat certain infections caused by methicillin-resistant Staphylococcus aureus, such as skin infections, sepsis, endocarditis, bone & joint infections, and meningitis. Inflammatory medicines are usually administered as a first-line treatment, with doses adjusted according to the patient's blood concentration.
Blood levels can be examined to determine the correct dose. When taken through the parenteral route, it is also suggested as a treatment for severe clostridium difficile colitis. When taken by mouth, it is poorly absorbed. Adverse effects such as injection site pain and allergic reactions are prevalent. It's also probably safe to use when breastfeeding. It's a glycopeptide antibiotic that works by inhibiting cell walls from forming.
Vancomycin demand is predicted to grow due to rising prevalence of infectious diseases, increased awareness programs, and government financing for the research and development of new treatments. The market is predicted to expand at a 5.8% CAGR from 2021 to 2027.
Which Market Growth Trends are Driving Consumption of Vancomycin?
“Positive Mechanism of Vancomycin & Rising Investments in R&D Activities to Foster Market Expansion”
The bactericidal activity of vancomycin is mostly due to its reduction of cell-wall formation. It prevents N-acetylmuramic acid and N-acetylglucosamine peptide subunits from being incorporated into the peptidoglycan matrix, the most critical structural component of Gram-positive cell walls.
Vancomycin forms hydrogen bonds with D-alanyl-D-alanine moieties at the end of the peptide, preventing them from being integrated into the peptidoglycan matrix. It also has an impact on bacterial cell membrane permeability and RNA synthesis.
No cross-resistance occurs between vancomycin and other antibiotic medications. Vancomycin does not have any effect on gram-negative bacteria, mycobacteria, or even fungi in vitro.
The global vancomycin industry is growing as antibiotic consumption rises in low- and middle-income nations, with pharmaceutical companies investing heavily in research and development, besides the rising prevalence of infectious diseases.
What Might Restrain Demand for Vancomycin to Some Extent?
“Rising Use of Generic Alternatives & Certain Side Effects Hampering Market Value”
Two typical adverse drug reactions associated with IV vancomycin are severe local pain and thrombophlebitis (which affect about 1% of patients). Clinical experiments conducted in the mid-1950s revealed that early impure versions of vancomycin tablets caused kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Nephrotoxicity was discovered to be a rare adverse effect in later investigations using purer forms of vancomycin (0.1% to 1% of patients).
Certain limitations, such as rising use of generic alternatives, particularly as patents expire, and short lifecycle of medications, are expected to hinder vancomycin market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regional Vancomycin Market is Leading Revenue Generation?
“Rise in VRSA Infections to Boost Market Revenue in North America”
North America is expected to hold a significant share of the global vancomycin market because of rising vancomycin-resistant Staphylococcus aureus (VRSA) infections, increased R&D initiatives, and rising demand for new treatments.
The developed healthcare sector and increased consumer awareness about various treatments for infectious illnesses are driving market growth in North America.
Country-wise Insights
Why is the U.S. an Emerging Market for Vancomycin Suppliers?
“Rapid Deployment of Innovative Treatments Driving Market Expansion”
The U.S. vancomycin market was valued at US$ 84.5 Mn in 2020 and is anticipated to rise at the highest CAGR over the forecast period.
The United States is expected to provide lucrative revenue growth possibilities for vancomycin suppliers because of rising consumer healthcare spending and early acceptance of innovative and new treatments.
Existence of prominent manufacturers and advanced healthcare facilities are driving market growth in the U.S. The United States is projected to dominate the market owing to the growing usage of superior technical equipment and well-established healthcare infrastructure.
What is the Vancomycin Market Outlook for China?
“Government Initiatives for Infection Control to Fuel Market Growth”
The market in China is projected to reach a valuation of US$ 102.3 Mn by 2027, representing a 9.4% CAGR from 2021 to 2027.
China is expected to occupy a considerable share of the global vancomycin market due to rising population, greater healthcare awareness, and higher demand for early-phase identification.
Growing number of pharmaceutical manufacturers, government help for infection control, and widespread use of generic drugs are driving market expansion in the country.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Vancomycin Type Accounts for Highest Revenue Generation?
“Growing Usage of Linezolid for Infection Prevention”
Linezolid is a drug that is used to treat infections such as pneumonia and skin diseases. Linezolid belongs to the oxazolidinones class of antibacterials. It works by preventing bacteria from growing.
The linezolid segment is projected to occupy a significant share of the global vancomycin market due to growing usage of linezolid and its capacity to treat a variety of gram-positive bacterial infections. Moreover, improved disease diagnostic techniques, as well as increased research on combination medicines, will drive market demand.
Which Application Will Emerge as Key Market Contributor?
“Increasing Consumption of Sepsis Drugs & Treatments Driving Market Demand”
According to the Centers for Disease Control and Prevention (CDC), there are roughly 1.7 million instances of sepsis each year. Furthermore, in the United States, this sort of illness kills nearly 270,000 people each year.
The body's severe response to an infection is known as sepsis. Sepsis occurs when an existing infection sets off a chain reaction throughout the body. Sepsis can quickly progress to tissue damage, organ failure, and death if not treated promptly.
Sepsis drugs and treatments are cost-effective and considered the first line of treatment, making the sepsis application segment the most profitable over the forecast period.
COVID-19 Impact on Vancomycin Consumption
The COVID-19 pandemic triggered an unprecedented global scenario, with healthcare at its core. The pandemic damaged several enterprises' value and supply chains, notably the vancomycin industry.
With rapid spread of the disease, several economies and sectors were disrupted, resulting in a recession as offices, factories, and markets closed. As a result, vancomycin demand and supply were suspended, resulting in a significant drop in the growth of extended-release antibiotics. Furthermore, the number of patients visiting hospitals and clinics decreased, resulting in a fall in treatment rates.
However, advances in medical research and the development of novel therapies and treatments to effectively treat a variety of health-related disorders have resulted in an increase in the demand for novel medications. With the reopening of economies and markets, extended vancomycin demand is projected to recover from the current downturn.
Competitive Landscape
Vancomycin is a competitive and moderately fragmented market. There are many players in the sector under scrutiny, including both, small and large pharmaceutical companies. Furthermore, a wave of early-stage biotech companies has entered the market in response to developing antibiotic resistance.
For instance :
- In February 2022, Magnolia Medical Technologies, Inc., the producer of Steripath®, which is the only FDA 510(k)-complaint device platform for the reduction of blood culture contamination for sepsis testing1, revealed US$ 46 million of growth equity financing led by RTW Investments, LP ("RTW"), and Sectoral Asset Management.
Key Segments Covered in Vancomycin Industry Research
-
Vancomycin Market by Type :
- Daptomycin
- Linezolid
- Quinupristin
- Ampicillin
- Chloramphenicol
- Others
-
Vancomycin Market by Application :
- Sepsis
- Lung Infection
- Skin Soft Tissue Infection
- Colitis & Intestinal Inflammation
- Other Infections
-
Vancomycin Market by Region :
- North America Vancomycin Market
- Europe Vancomycin Market
- Asia Pacific Vancomycin Market
- Latin America Vancomycin Market
- MEA Vancomycin Market
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product Launches 5.2.2. Cost of Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as Compared to 2008 Economic Analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Type 6.1.4.2. Revenue By Application 6.1.4.3. Revenue By Country 6.1.5. 2020 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Vancomycin Market Volume (Units) Analysis 2017-2020 and Forecast, 2021-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2020 7.2. Current and Future Market Volume (Units) Projections, 2021-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Vancomycin Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Vancomycin Market Value Analysis 2017–2020 and Forecast, 2021-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2017–2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2021-2027 10.3.1. Daptomycin 10.3.2. Linezolid 10.3.3. Quinupristin 10.3.4. Ampicillin 10.3.5. Chloramphenico 10.3.6. Others 10.4. Market Attractiveness Analysis By Type 11. Global Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2017–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2021-2027 11.3.1. Sepsis 11.3.2. Lung Infection 11.3.3. Skin Soft Tissue Infection 11.3.4. Colitis & Intestinal Inflammation 11.3.5. Other Infections 11.4. Market Attractiveness Analysis By Application 12. Global Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2020 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2020 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Vancomycin Market Analysis 2017–2020 and Forecast 2021-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Vancomycin Market Analysis 20.2.1. By Type 20.2.2. By Application 20.3. Canada Vancomycin Market Analysis 20.3.1. By Type 20.3.2. By Application 20.4. Mexico Vancomycin Market Analysis 20.4.1. By Type 20.4.2. By Application 20.5. Brazil Vancomycin Market Analysis 20.5.1. By Type 20.5.2. By Application 20.6. U.K. Vancomycin Market Analysis 20.6.1. By Type 20.6.2. By Application 20.7. Germany Vancomycin Market Analysis 20.7.1. By Type 20.7.2. By Application 20.8. France Vancomycin Market Analysis 20.8.1. By Type 20.8.2. By Application 20.9. Italy Vancomycin Market Analysis 20.9.1. By Type 20.9.2. By Application 20.10. Spain Vancomycin Market Analysis 20.10.1. By Type 20.10.2. By Application 20.11. BENELUX Vancomycin Market Analysis 20.11.1. By Type 20.11.2. By Application 20.12. Russia Vancomycin Market Analysis 20.12.1. By Type 20.12.2. By Application 20.13. China Vancomycin Market Analysis 20.13.1. By Type 20.13.2. By Application 20.14. Japan Vancomycin Market Analysis 20.14.1. By Type 20.14.2. By Application 20.15. South Korea Vancomycin Market Analysis 20.15.1. By Type 20.15.2. By Application 20.16. India Vancomycin Market Analysis 20.16.1. By Type 20.16.2. By Application 20.17. ASEAN Vancomycin Market Analysis 20.17.1. By Type 20.17.2. By Application 20.18. Australia Vancomycin Market Analysis 20.18.1. By Type 20.18.2. By Application 20.19. New Zealand Vancomycin Market Analysis 20.19.1. By Type 20.19.2. By Application 20.20. GCC Countries Vancomycin Market Analysis 20.20.1. By Type 20.20.2. By Application 20.21. Turkey Vancomycin Market Analysis 20.21.1. By Type 20.21.2. By Application 20.22. South Africa Vancomycin Market Analysis 20.22.1. By Type 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Alvogen 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. MGB Biopharma Limited 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Oragenics 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Aphios Corporation 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Microbiotix 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Vancomycin Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Type
Table 02: Global Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 03: Global Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 04: Global Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 06: North America Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 07: North America Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 08: Latin America Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 09: Latin America Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 10: Latin America Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 11: Europe Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 12: Europe Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 13: Europe Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 14: South Asia Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 15: South Asia Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 16: South Asia Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 17: East Asia Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 18: East Asia Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 19: East Asia Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 20: Oceania Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 21: Oceania Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 22: Oceania Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
Table 23: Middle East and Africa Vancomycin Market Value (US$ Mn) Analysis 2017-2020 and Forecast 2021–2027, By Country
Table 24: Middle East and Africa Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type
Table 25: Middle East and Africa Vancomycin Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Vancomycin Market Volume (in 000' Units) Analysis, 2017-2020
Figure 02: Global Vancomycin Market Volume Forecast (in 000' Units), 2021-2027
Figure 03: Vancomycin Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Vancomycin Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 06: Global Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 07: Global Vancomycin Market Absolute $ Opportunity, 2021-2027
Figure 08: Global Vancomycin Market Share Analysis (%), By Type, 2021-2027
Figure 09: Global Vancomycin Market Y-o-Y Analysis (%), By Type, 2021-2027
Figure 10: Global Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 11: Global Vancomycin Market Share Analysis (%), By Application, 2021-2027
Figure 12: Global Vancomycin Market Y-o-Y Analysis (%), By Application, 2021-2027
Figure 13: Global Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 14: Global Vancomycin Market Share Analysis (%), By Region, 2021-2027
Figure 15: Global Vancomycin Market Y-o-Y Analysis (%), By Region, 2021-2027
Figure 16: Global Vancomycin Market Attractiveness Analysis by Region, 2021-2027
Figure 17: North America Vancomycin Market Value Share, By Type, 2021 (E)
Figure 18: North America Vancomycin Market Value Share, By Application, 2021 (E)
Figure 19: North America Vancomycin Market Value Share, By Country, 2021 (E)
Figure 20: North America Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 21: North America Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 22: North America Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 23: North America Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 24: North America Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 25: Latin America Vancomycin Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Vancomycin Market Value Share, By Application, 2021 (E)
Figure 27: Latin America Vancomycin Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 29: Latin America Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 30: Latin America Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 31: Latin America Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 32: Latin America Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 33: Europe Vancomycin Market Value Share, By Type, 2021 (E)
Figure 34: Europe Vancomycin Market Value Share, By Application, 2021 (E)
Figure 35: Europe Vancomycin Market Value Share, By Country, 2021 (E)
Figure 36: Europe Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 37: Europe Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 38: Europe Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 39: Europe Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 40: Europe Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 41: South Asia Vancomycin Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Vancomycin Market Value Share, By Application, 2021 (E)
Figure 43: South Asia Vancomycin Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 45: South Asia Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 46: South Asia Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 47: South Asia Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 48: South Asia Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 49: East Asia Vancomycin Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Vancomycin Market Value Share, By Application, 2021 (E)
Figure 51: East Asia Vancomycin Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 53: East Asia Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 54: East Asia Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 55: East Asia Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 56: East Asia Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 57: Oceania Vancomycin Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Vancomycin Market Value Share, By Application, 2021 (E)
Figure 59: Oceania Vancomycin Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 61: Oceania Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 62: Oceania Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 63: Oceania Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 64: Oceania Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 65: Middle East and Africa Vancomycin Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa Vancomycin Market Value Share, By Application, 2021 (E)
Figure 67: Middle East and Africa Vancomycin Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Vancomycin Market Value Analysis (US$ Mn), 2017-2020
Figure 69: Middle East and Africa Vancomycin Market Value Forecast (US$ Mn), 2021-2027
Figure 70: Middle East and Africa Vancomycin Market Attractiveness Analysis by Type, 2021-2027
Figure 71: Middle East and Africa Vancomycin Market Attractiveness Analysis by Application, 2021-2027
Figure 72: Middle East and Africa Vancomycin Market Attractiveness Analysis by Country, 2021-2027
Figure 73: U. S. Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 74: U. S. Vancomycin Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Vancomycin Market Value Share, By Application, 2021 (E)
Figure 76: Canada Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 77: Canada Vancomycin Market Value Share, By Type, 2021 (E)
Figure 78: Canada Vancomycin Market Value Share, By Application, 2021 (E)
Figure 79: Mexico Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 80: Mexico Vancomycin Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Vancomycin Market Value Share, By Application, 2021 (E)
Figure 82: Brazil Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 83: Brazil Vancomycin Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Vancomycin Market Value Share, By Application, 2021 (E)
Figure 85: U. K. Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 86: U. K. Vancomycin Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Vancomycin Market Value Share, By Application, 2021 (E)
Figure 88: Germany Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 89: Germany Vancomycin Market Value Share, By Type, 2021 (E)
Figure 90: Germany Vancomycin Market Value Share, By Application, 2021 (E)
Figure 91: France Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 92: France Vancomycin Market Value Share, By Type, 2021 (E)
Figure 93: France Vancomycin Market Value Share, By Application, 2021 (E)
Figure 94: Italy Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 95: Italy Vancomycin Market Value Share, By Type, 2021 (E)
Figure 96: Italy Vancomycin Market Value Share, By Application, 2021 (E)
Figure 97: Spain Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 98: Spain Vancomycin Market Value Share, By Type, 2021 (E)
Figure 99: Spain Vancomycin Market Value Share, By Application, 2021 (E)
Figure 100: Russia Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 101: Russia Vancomycin Market Value Share, By Type, 2021 (E)
Figure 102: Russia Vancomycin Market Value Share, By Application, 2021 (E)
Figure 103: China Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 104: China Vancomycin Market Value Share, By Type, 2021 (E)
Figure 105: China Vancomycin Market Value Share, By Application, 2021 (E)
Figure 106: Japan Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 107: Japan Vancomycin Market Value Share, By Type, 2021 (E)
Figure 108: Japan Vancomycin Market Value Share, By Application, 2021 (E)
Figure 109: South Korea Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 110: South Korea Vancomycin Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Vancomycin Market Value Share, By Application, 2021 (E)
Figure 112: India Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 113: India Vancomycin Market Value Share, By Type, 2021 (E)
Figure 114: India Vancomycin Market Value Share, By Application, 2021 (E)
Figure 115: ASEAN Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 116: ASEAN Vancomycin Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Vancomycin Market Value Share, By Application, 2021 (E)
Figure 118: Australia Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 119: Australia Vancomycin Market Value Share, By Type, 2021 (E)
Figure 120: Australia Vancomycin Market Value Share, By Application, 2021 (E)
Figure 121: New Zealand Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 122: New Zealand Vancomycin Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Vancomycin Market Value Share, By Application, 2021 (E)
Figure 124: GCC Countries Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 125: GCC Countries Vancomycin Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Vancomycin Market Value Share, By Application, 2021 (E)
Figure 127: Turkey Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 128: Turkey Vancomycin Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Vancomycin Market Value Share, By Application, 2021 (E)
Figure 130: South Africa Vancomycin Market Value Analysis (US$ Mn), 2021 & 2027
Figure 131: South Africa Vancomycin Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Vancomycin Market Value Share, By Application, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big was the vancomycin market in 2021?
In 2021, the global vancomycin market stood at a valuation of US$ 331.5 Mn.
What will the China vancomycin market be worth by 2027?
The China vancomycin market is anticipated to reach US$ 102.3 Mn by 2027.
What valuation will the vancomycin market reach by 2027?
Vancomycin sales are expected to reach US$ 465.1 Mn by 2027.
What is the predicted CAGR for the global vancomycin market over the forecast period?
From 2021 to 2027, global consumption of vancomycin is predicted to rise at a CAGR of 5.8%.
Who are the key suppliers of vancomycin?
Key suppliers of vancomycin are Alvogen, MGB Biopharma Limited, Oragenics, Aphios Corporation, and Microbiotix.
What are the key market statistics for vancomycin in Japan and Canada?
The market in Japan is expected to exhibit 3.1% CAGR, while Japan is set to experience a higher 4.6% CAGR, over the forecast period.
Vancomycin Market